In Vivo Effects of Cyclooxygenase-2 Deletion on Cellular Signaling in Hepatocellular Carcinoma Xenografts in Nude Mice

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Unknown venue

• Publication date

  2007-04-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.29685/JCM.200704.0003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Histone deacetylases and cancer

  2007cited by this paper
• Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod

  2007cited by this paper
• Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines.

  2007cited by this paper
• The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.

  2006cited by this paper
• Histone deacetylase inhibitors: multifunctional anticancer agents.

  2006cited by this paper
• Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases.

  2005cited by this paper
• Increased expression of histone deacetylase 2 is found in human gastric cancer

  2005cited by this paper
• Mechanisms of Disease: PI3K/AKT Signaling in Gastrointestinal Cancers

  2005cited by this paper
• Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.

  2005cited by this paper
• Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression

  2005cited by this paper
• In vitro and In vivo Effects and Mechanisms of Celecoxib-Induced Growth Inhibition of Human Hepatocellular Carcinoma Cells

  2005cited by this paper
• Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.

  2005cited by this paper
• Cyclooxygenase-2 Promotes Human Cholangiocarcinoma Growth

  2004cited by this paper
• PI3K-Akt pathway: Its functions and alterations in human cancer

  2004cited by this paper
• Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.

  2004cited by this paper
• High α‐fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β‐catenin mutations

  2004cited by this paper
• Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity.

  2004cited by this paper
• PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells.

  2003cited by this paper
• Histone deacetylases (HDACs): characterization of the classical HDAC family.

  2003cited by this paper
• Cyclooxygenase‐2 promotes hepatocellular carcinoma cell growth through AKT activation: Evidence for AKT inhibition in celecoxib‐induced apoptosis

  2003cited by this paper
• AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.

  2002cited by this paper
• Rationale and feasibility of chemoprovention of hepatocellular carcinoma by cyclooxygenase-2 inhibitors.

  2002cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• Histone deacetylases and cancer: causes and therapies

  2001cited by this paper
• PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?

  2001cited by this paper
• Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States

  2001cited by this paper
• Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin.

  2001cited by this paper
• The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma.

  2001cited by this paper
• Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells*

  2001cited by this paper
• AKT plays a central role in tumorigenesis

  2001cited by this paper
• Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia

  2000cited by this paper
• Histone deacetylases, transcriptional control, and cancer

  2000cited by this paper
• The role of cyclooxygenases in inflammation, cancer, and development

  1999cited by this paper
• Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects*

  1999cited by this paper
• Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase

  1999cited by this paper
• Rising Incidence of Hepatocellular Carcinoma in the United States

  1999cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Significance of alpha‐fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection

  1997cited by this paper
• Increased MAPK expression and activity in primary human hepatocellular carcinoma.

  1997cited by this paper
• Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II

  1995cited by this paper

• Studying the Anticancer Properties of Bone Marrow-Derived Mesenchymal Stem Cells against Hepatocellular Carcinoma Induced by N-Nitrosodiethylamine in Male Rats

  2022cites this paper
• Evidences for the antitumor potentiality of Hemimycale arabica and Negombata magnifica mesohyls in hepatocellular carcinoma rat model

  2018cites this paper
• Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study

  2017cites this paper
• Updates on the Biochemical and Molecular Mechanisms of N-nitrosodiethylamine-induced Hepatocellular Carcinoma: Promising Therapeutic Role of Punica granatum Peel Extract

  2015cites this paper
• Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat model

  2015cites this paper
• The Mechanism of Action of Thymus sp. for Inducing Apoptosis and Fighting Cancer

  2014cites this paper
• Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice.

  2009influential citation
• In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice

  2008cites this paper